(Q36531876)

14 August 2017

1 reference

title

Iron indices: what do they really mean? (English)

1 reference

14 August 2017

Coyne D

1

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Kidney International. Supplement

14 August 2017

published in

1 reference

14 August 2017

issue

101

1 reference

14 August 2017

page(s)

S4-8

1 reference

Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic Patients

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Cardiac function and hematocrit level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Iron requirements in erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Laboratory diagnosis of iron-deficiency anemia: an overview

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Time-dependent associations between iron and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Epidemiology of vascular disease in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Administration of parenteral iron and mortality among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

A randomized trial of iron deficiency testing strategies in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

HFE genotype in patients with hemochromatosis and other liver diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

A clinical evaluation of serum ferritin as an index of iron stores

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000404

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000404

0 references

1 reference